Recent advances in AI have significantly contributed towards the transformation of the life sciences Industry.  While these changes will ultimately benefit our industry in the long run, we are not yet fully prepared for them. The adoption of generative AI systems, designed for human-like interactivity, raises questions that we are not just unprepared to answer but may not have even considered yet.

For this interactive, live discussion, Walter Boyle, Cytel’s Global Head of Axio, will be joined by an expert on data and AI ethics, Allie DeLonay, Senior Data Scientist at SAS’s Data Ethics Practice (DEP).  Walter and Allie will discuss key topics around the ethical use of AI, both broadly and within the context of clinical development.

Speakers

Walter Boyle, VP of DMC Biostatistics at Cytel